Andhra University, College of Pharmaceutical Sciences Visakhapatnam (AU, CLG. PHARMA. SCI. VISHAKHAPATNA) - Courses & Fees
NAAC A, PCI
AU VISAKHAPATNAM
Visakhapatnam, Andhra Pradesh
NAAC A, PCI
AU VISAKHAPATNAM
Visakhapatnam, Andhra Pradesh
Courses & Fees (5)
Bachelor of Pharmacy (B.PHARM)
Type of Course
Under Graduation
Course Duration
4 years
Study Modes
Full Time
Course Fees
₹ 1,200,288
Detailed Distribution of Fees:
Year 1 | Year 2 | Year 3 | Year 4 |
|---|---|---|---|
| ₹ 329,988 | ₹ 290,100 | ₹ 290,100 | ₹ 290,100 |
Branches:
General [GEN]
Master of Pharmacy (M.PHARM)
Type of Course
Post Graduation
Course Duration
2 years
Study Modes
Full Time
Course Fees
₹ 605,583
Detailed Distribution of Fees:
Year 1 | Year 2 |
|---|---|
| ₹ 315,483 | ₹ 290,100 |
Branches:
Pharmacology [PHARMAGY], Drug Regulatory Affairs [DRA], Pharmaceutical Biotechnology [PHARMA BIO], Pharmaceutical Chemistry [PHARMA CHEM], Pharmaceutical Technology [PHARMA TECH], Pharmacognosy [PHARMSY], Pharmacy Practice [PHARMA PRA]
Doctor of Philosophy in Pharmacy (Ph.D. (PHARMA))
Type of Course
Doctorate
Course Duration
4 years
Study Modes
Full Time
Course Fees
₹ 902,920
Detailed Distribution of Fees:
Year 1 | Year 2 | Year 3 |
|---|---|---|
| ₹ 322,720 | ₹ 290,100 | ₹ 290,100 |
Branches:
Pharmacology [PHARMAGY], Biotechnology [BIOTECH], Pharmaceutical Chemistry [PHARMA CHEM], Pharmaceutical Technology [PHARMA TECH], Pharmacognosy [PHARMSY], Pharmacy Practice [PHARMA PRA]
Doctor of Pharmacy (PHARMA D)
Type of Course
Post Graduation
Course Duration
6 years
Study Modes
Full Time
Course Fees
₹ 1,794,993
Detailed Distribution of Fees:
Year 1 | Year 2 | Year 3 | Year 4 | Year 5 | Year 6 |
|---|---|---|---|---|---|
| ₹ 344,493 | ₹ 290,100 | ₹ 290,100 | ₹ 290,100 | ₹ 290,100 | ₹ 290,100 |
Branches:
General [GEN]
Pharma. D (Post Baccalaureate) (PD (PB))
Type of Course
Post Graduation
Course Duration
3 years
Study Modes
Full Time
Course Fees
₹ 924,693
Detailed Distribution of Fees:
Year 1 | Year 2 | Year 3 |
|---|---|---|
| ₹ 344,493 | ₹ 290,100 | ₹ 290,100 |
Comments